DOI QR코드

DOI QR Code

Evaluation of mesenchymal stem cells-derived exosomes and conditioned medium as a potential treatment for induced type 1 diabetes mellitus in adult male albino rats

  • Walaa E. Omar (Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Zagazig University) ;
  • Asmaa M. Tolba (Department of Human Anatomy and Embryology, Faculty of Medicine, Zagazig University) ;
  • Emtethal M. El-Bestawy (Department of Human Anatomy and Embryology, Faculty of Medicine, Zagazig University) ;
  • Asmaa A. Ibrahim (Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Zagazig University) ;
  • Basma A. Ibrahim (Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Zagazig University)
  • 투고 : 2025.05.28
  • 심사 : 2025.09.10
  • 발행 : 2026.03.31

초록

Diabetes mellitus (DM) is a metabolic condition marked by disrupted insulin regulation. Mesenchymal stem cell-derived exosomes and conditioned medium (CM) have emerged as promising therapeutic candidates for DM. This research explored the medical benefits of exosomes and CM in treating streptozotocin-induced type 1 DM (T1DM) in rats, comparing their efficacy to bone marrow-derived mesenchymal stem cells (BM-MSCs). Fifty albino rats were grouped into five groups (n=10 each): healthy controls, untreated T1DM rats, T1DM rats treated with intravenous BM-MSCs, T1DM rats treated with intravenous exosomes, and T1DM rats treated with intravenous CM. Plasma glucose and insulin concentrations were monitored weekly. Pancreatic β-cell regeneration was analyzed via qRT-PCR, focusing on the expression levels of TGF-β, Smad3, Ngn3, Pdx1, MafA, and insulin genes. Histological evaluation of pancreatic tissue regeneration was performed at weeks 2 and 4 using hematoxylin & eosin and Masson's trichrome stains. The exosomes- and CM-treated groups demonstrated significantly higher expression of β-cell regeneration markers (TGF-β, Smad3, Ngn3, Pdx1, MafA, and insulin) than the BM-MSCs group. Additionally, these groups demonstrated a marked rise in the area percentage of pancreatic islets and a significant reduction in pancreatic fibrosis, with more pronounced effects at week 4. Exosomes and CM exhibit superior therapeutic efficiency and regenerative potential over BM-MSCs in T1DM, suggesting their promise as cell-free alternatives for diabetes treatment.

키워드

과제정보

The authors extend their gratitude to the Stem Cell Research Unit and Molecular Biology Laboratory at the Medical Biochemistry Department, Faculty of Medicine, Zagazig University, Egypt, for facilitating the experimental work. They also deeply appreciate the assistance and support offered by the staff of the Animal House at Zagazig University Hospitals.

참고문헌

  1. Leete P. Type 1 diabetes in the pancreas: a histological perspective. Diabet Med 2023;40:e15228. https://doi.org/10.1111/dme.v40.12
  2. Saeedi P, Salpea P, Karuranga S, Petersohn I, Malanda B, Gregg EW, Unwin N, Wild SH, Williams R. Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2020;162:108086. https://doi.org/10.1016/j.diabres.2020.108086
  3. Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, Jacobsen LM, Schatz DA, Lernmark Å. Type 1 diabetes mellitus. Nat Rev Dis Primers 2017;3:17016. https://doi.org/10.1038/nrdp.2017.16
  4. Berney T, Wassmer CH, Lebreton F, Bellofatto K, Fonseca LM, Bignard J, Hanna R, Peloso A, Berishvili E. From islet of Langerhans transplantation to the bioartificial pancreas. Presse Med 2022;51:104139. https://doi.org/10.1016/j.lpm.2022.104139
  5. Xiang E, Han B, Zhang Q, Rao W, Wang Z, Chang C, Zhang Y, Tu C, Li C, Wu D. Human umbilical cord-derived mesen-chymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Stem Cell Res Ther 2020;11:336. https://doi.org/10.1186/s13287-020-01852-y
  6. Chen L, Zhang J, Yang L, Zhang G, Wang Y, Zhang S. The effects of conditioned medium derived from mesenchymal stem cells cocultured with hepatocytes on damaged hepatocytes and acute liver failure in rats. Stem Cells Int 2018;2018:9156560. https://doi.org/10.1155/2018/9156560
  7. Ebrahim N, Ahmed IA, Hussien NI, Dessouky AA, Farid AS, Elshazly AM, Mostafa O, Gazzar WBE, Sorour SM, Seleem Y, Hussein AM, Sabry D. Mesenchymal stem cell-derived exosomes ameliorated diabetic nephropathy by autophagy induction through the mTOR signaling pathway. Cells 2018;7:226. https://doi.org/10.3390/cells7120226
  8. Isildar B, Ozkan S, Koyuturk M. Therapeutic potential of mesenchymal stem cell-derived conditioned medium for diabetes mellitus and related complications. Adv Therap 2023;6:2300216.
  9. Zhuang WZ, Lin YH, Su LJ, Wu MS, Jeng HY, Chang HC, Huang YH, Ling TY. Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications. J Biomed Sci 2021;28:28. https://doi.org/10.1186/s12929-021-00725-7
  10. Nagaishi K, Mizue Y, Chikenji T, Otani M, Nakano M, Konari N, Fujimiya M. Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes. Sci Rep 2016;6:34842. https://doi.org/10.1038/srep34842
  11. Dahbour S, Jamali F, Alhattab D, Al-Radaideh A, Ababneh O, Al-Ryalat N, Al-Bdour M, Hourani B, Msallam M, Rasheed M, Huneiti A, Bahou Y, Tarawneh E, Awidi A. Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: clinical, ophthalmological and radiological assessments of safety and efficacy. CNS Neurosci Ther 2017;23:866-74. https://doi.org/10.1111/cns.2017.23.issue-11
  12. Mathew B, Ravindran S, Liu X, Torres L, Chennakesavalu M, Huang CC, Feng L, Zelka R, Lopez J, Sharma M, Roth S. Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion. Biomaterials 2019;197:146-60. https://doi.org/10.1016/j.biomaterials.2019.01.016
  13. Hashemi SM, Hassan ZM, Hossein-Khannazer N, Pourfathollah AA, Soudi S. Investigating the route of administration and efficacy of adipose tissue-derived mesenchymal stem cells and conditioned medium in type 1 diabetic mice. Inflammopharmacology 2020;28:585-601. https://doi.org/10.1007/s10787-019-00661-x
  14. Gao X, Song L, Shen K, Wang H, Qian M, Niu W, Qin X. Bone marrow mesenchymal stem cells promote the repair of islets from diabetic mice through paracrine actions. Mol Cell Endocrinol 2014;388:41-50. https://doi.org/10.1016/j.mce.2014.03.004
  15. Shin S, Lee J, Kwon Y, Park KS, Jeong JH, Choi SJ, Bang SI, Chang JW, Lee C. Comparative proteomic analysis of the mesenchymal stem cells secretome from adipose, bone marrow, placenta and Wharton's jelly. Int J Mol Sci 2021;22:845. https://doi.org/10.3390/ijms22020845
  16. Tan F, Li X, Wang Z, Li J, Shahzad K, Zheng J. Clinical applications of stem cell-derived exosomes. Signal Transduct Target Ther 2024;9:17. https://doi.org/10.1038/s41392-023-01704-0
  17. Shabbir A, Cox A, Rodriguez-Menocal L, Salgado M, Van Badiavas E. Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro. Stem Cells Dev 2015;24:1635-47. https://doi.org/10.1089/scd.2014.0316
  18. Nakano M, Kubota K, Kobayashi E, Chikenji TS, Saito Y, Konari N, Fujimiya M. Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer's disease model by increasing the expression of microRNA-146a in hippocampus. Sci Rep 2020;10:10772. https://doi.org/10.1038/s41598-020-67460-1
  19. Xiong J, Hu H, Guo R, Wang H, Jiang H. Mesenchymal stem cell exosomes as a new strategy for the treatment of diabetes complications. Front Endocrinol (Lausanne) 2021;12:646233. https://doi.org/10.3389/fendo.2021.646233
  20. Jiao YR, Chen KX, Tang X, Tang YL, Yang HL, Yin YL, Li CJ. Exosomes derived from mesenchymal stem cells in diabetes and diabetic complications. Cell Death Dis 2024;15:271. https://doi.org/10.1038/s41419-024-06659-w
  21. Keshtkar S, Azarpira N, Ghahremani MH. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther 2018;9:63. https://doi.org/10.1186/s13287-018-0791-7
  22. Zhang F, Wang C, Wen X, Chen Y, Mao R, Cui D, Li L, Liu J, Chen Y, Cheng J, Lu Y. Mesenchymal stem cells alleviate rat diabetic nephropathy by suppressing CD103+ DCs-mediated CD8+ T cell responses. J Cell Mol Med 2020;24:5817-31. https://doi.org/10.1111/jcmm.v24.10
  23. Wang J, Mi Y, Wu S, You X, Huang Y, Zhu J, Zhu L. Exosomes from adipose-derived stem cells protect against high glucoseinduced erectile dysfunction by delivery of corin in a streptozotocin-induced diabetic rat model. Regen Ther 2020;14:227-33. https://doi.org/10.1016/j.reth.2020.03.002
  24. Masithoh DBH, Fibrianto YH, Anggita M, Nugroho WS, Budipitojo T. PCS-11: mesenchymal stem cell-conditioned medium improve the recovery of pancreatic α and β cells in type 1 diabetes mellitus. Paper presented at: Proceedings of the 20th FAVA CONGRESS & The 15th KIVNAS PDHI; 2018 Nov 1-3; Bali, Indonesia. p. 172-4.
  25. Ghasemi A, Jeddi S. Streptozotocin as a tool for induction of rat models of diabetes: a practical guide. EXCLI J 2023;22:274-94.
  26. Espina M, Jülke H, Brehm W, Ribitsch I, Winter K, Delling U. Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses. PeerJ 2016;4:e1773. https://doi.org/10.7717/peerj.1773
  27. Gu X, Li Y, Chen K, Wang X, Wang Z, Lian H, Lin Y, Rong X, Chu M, Lin J, Guo X. Exosomes derived from umbilical cord mesenchymal stem cells alleviate viral myocarditis through activating AMPK/mTOR-mediated autophagy flux pathway. J Cell Mol Med 2020;24:7515-30. https://doi.org/10.1111/jcmm.v24.13
  28. Nikfarjam S, Rezaie J, Zolbanin NM, Jafari R. Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine. J Transl Med 2020;18:449. https://doi.org/10.1186/s12967-020-02622-3
  29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8. https://doi.org/10.1006/meth.2001.1262
  30. Suvarna KS, Layton C, Bancroft JD. Bancroft's theory and practice of histological techniques: e-book chapter 4. 8th ed. Elsevier; 2019. p. 56-8.
  31. Farid A, El-Alfy L, Madbouly N. Bone marrow-derived mesenchymal stem cells transplantation downregulates pancreatic NF-κB and pro-inflammatory cytokine profile in rats with type I and type II-induced diabetes: a comparison study. Biologia 2023;78:3165-77. https://doi.org/10.1007/s11756-023-01436-0
  32. El Barky AR, Ezz AAH, Alm-Eldeen AA, Hussein SA, Hafez YA, Mohamed TM. Can stem cells ameliorate the pancreatic damage induced by streptozotocin in rats? Can J Diabetes 2018;42:61-70. https://doi.org/10.1016/j.jcjd.2017.04.002
  33. Carlsson PO, Schwarcz E, Korsgren O, Le Blanc K. Preserved β-cell function in type 1 diabetes by mesenchymal stromal cells. Diabetes 2015;64:587-92. https://doi.org/10.2337/db14-0656
  34. Sun Y, Shi H, Yin S, Ji C, Zhang X, Zhang B, Wu P, Shi Y, Mao F, Yan Y, Xu W, Qian H. Human mesenchymal stem cell derived exosomes alleviate type 2 diabetes mellitus by reversing peripheral insulin resistance and relieving β-cell destruction. ACS Nano 2018;12:7613-28. https://doi.org/10.1021/acsnano.7b07643
  35. Keshtkar S, Kaviani M, Sarvestani FS, Ghahremani MH, Aghdaei MH, Al-Abdullah IH, Azarpira N. Exosomes derived from human mesenchymal stem cells preserve mouse islet survival and insulin secretion function. EXCLI J 2020;19:1064-80.
  36. Nugroho WS, Kusindarta DL, Susetya H, Fitriana I, Mulyani GT, Fibrianto YH, Haryanto A, Budipitojo T. The structural and functional recovery of pancreatic β-cells in type 1 diabetes mellitus induced mesenchymal stem cell-conditioned medium. Vet World 2016;9:535-9. https://doi.org/10.14202/vetworld.
  37. Carvalho MM, Teixeira FG, Reis RL, Sousa N, Salgado AJ. Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine. Curr Stem Cell Res Ther 2011;6:221-8. https://doi.org/10.2174/157488811796575332
  38. Pawitan JA. Prospect of stem cell conditioned medium in regenerative medicine. Biomed Res Int 2014;2014:965849. https://doi.org/10.1155/2014/965849
  39. Laksmitawati DR, Noor SU, Sumiyati Y, Hartanto A, Widowati W, Pratami DK. The effect of mesenchymal stem cell-conditioned medium gel on burn wound healing in rat. Vet World 2022;15:841-7. https://doi.org/10.14202/vetworld.
  40. Wei B, Wei M, Huang H, Fan T, Zhang Z, Song X. Mesenchymal stem cell-derived exosomes: a promising therapeutic strategy for age-related diseases. Cell Prolif 2025;58:e13795. https://doi.org/10.1111/cpr.v58.5
  41. Gao Y, Zhang R, Dai S, Zhang X, Li X, Bai C. Role of TGF-β/Smad pathway in the transcription of pancreas-specific genes during beta cell differentiation. Front Cell Dev Biol 2019;7:351. https://doi.org/10.3389/fcell.2019.00351
  42. Xu X, Zheng L, Yuan Q, Zhen G, Crane JL, Zhou X, Cao X. Transforming growth factor-β in stem cells and tissue homeostasis. Bone Res 2018;6:2. https://doi.org/10.1038/s41413-017-0005-4
  43. Lin HM, Lee JH, Yadav H, Kamaraju AK, Liu E, Zhigang D, Vieira A, Kim SJ, Collins H, Matschinsky F, Harlan DM, Roberts AB, Rane SG. Transforming growth factor-beta/Smad3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function. J Biol Chem 2009;284:12246-57. https://doi.org/10.1074/jbc.M805379200
  44. Zhu Y, Liu Q, Zhou Z, Ikeda Y. PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration. Stem Cell Res Ther 2017;8:240. https://doi.org/10.1186/s13287-017-0694-z
  45. Ebrahim N, Shakirova K, Dashinimaev E. PDX1 is the cornerstone of pancreatic β-cell functions and identity. Front Mol Biosci 2022;9:1091757. https://doi.org/10.3389/fmolb.2022.1091757
  46. Nojehdehi S, Soudi S, Hesampour A, Rasouli S, Soleimani M, Hashemi SM. Immunomodulatory effects of mesenchymal stem cell-derived exosomes on experimental type-1 autoimmune diabetes. J Cell Biochem 2018;119:9433-43. https://doi.org/10.1002/jcb.v119.11
  47. Sabry D, Marzouk S, Zakaria R, Ibrahim HA, Samir M. The effect of exosomes derived from mesenchymal stem cells in the treatment of induced type 1 diabetes mellitus in rats. Biotechnol Lett 2020;42:1597-610. https://doi.org/10.1007/s10529-020-02908-y
  48. Zhang T, Wang H, Wang T, Wei C, Jiang H, Jiang S, Yang J, Shao J, Ma L. Pax4 synergistically acts with Pdx1, Ngn3 and MafA to induce HuMSCs to differentiate into functional pancreatic β-cells. Exp Ther Med 2019;18:2592-8. https://doi.org/10.3892/etm
  49. Usher ET, Showalter SA. Biophysical insights into glucose-dependent transcriptional regulation by PDX1. J Biol Chem 2022; 298:102623. https://doi.org/10.1016/j.jbc.2022.102623
  50. Al-Adsani AM, Al-Otaibi AN, Barhoush SA, Al-Qattan KK, Al-Bustan SA. Expression profiling of Pdx1, Ngn3, and MafA in the liver and pancreas of recovering streptozotocin-induced diabetic rats. Genes (Basel) 2022;13:1625. https://doi.org/10.3390/genes13091625
  51. Gribben C, Lambert C, Messal HA, Hubber EL, Rackham C, Evans I, Heimberg H, Jones P, Sancho R, Behrens A. Ductal Ngn3-expressing progenitors contribute to adult β cell neogenesis in the pancreas. Cell Stem Cell 2021;28:2000-8.e4. https://doi.org/10.1016/j.stem.2021.08.003
  52. Nishimura W, Iwasa H, Tumurkhuu M. Role of the transcription factor MAFA in the maintenance of pancreatic β-cells. Int J Mol Sci 2022;23:4478. https://doi.org/10.3390/ijms23094478
  53. Matsuoka TA, Kawashima S, Miyatsuka T, Sasaki S, Shimo N, Katakami N, Kawamori D, Takebe S, Herrera PL, Kaneto H, Stein R, Shimomura I. Mafa enables Pdx1 to effectively convert pancreatic islet progenitors and committed islet α-cells into β-cells in vivo. Diabetes 2017;66:1293-300. https://doi.org/10.2337/db16-0887
  54. Zhang Y, Bi J, Huang J, Tang Y, Du S, Li P. Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomedicine 2020;15: 6917-34. https://doi.org/10.2147/IJN.S264498
  55. Bagno LL, Salerno AG, Balkan W, Hare JM. Mechanism of action of mesenchymal stem cells (MSCs): impact of delivery method. Expert Opin Biol Ther 2022;22:449-63. https://doi.org/10.1080/14712598.2022.2016695
  56. Fuentes P, Torres MJ, Arancibia R, Aulestia F, Vergara M, Carrión F, Osses N, Altamirano C. Dynamic culture of mesenchymal stromal/stem cell spheroids and secretion of paracrine factors. Front Bioeng Biotechnol 2022;10:916229. https://doi.org/10.3389/fbioe.2022.916229
  57. Meligy FY, Mohammed HSE, Abou Elghait AT, Mohamed HK, Ashry IEM, Abdel-Rahman Sayed A, Hussein OA, Salman A, Atia T, Mohamed AS, Behnsawy NH, Gaber SS, Sakr HI, Ahmed SF. Mesenchymal stem cells versus mesenchymal stem cells-derived exosomes as potential autophagy pathway modulators in a diabetic model. Adv Med Sci 2025;70:152-65. https://doi.org/10.1016/j.advms.2025.02.004